Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing

26 Sept 2019

Abstract excerpt

OBJECTIVE In the U.S., genetic testing for maturity-onset diabetes of the young (MODY) is frequently delayed because of difficulty with insurance coverage. Understanding the economic implications of clinical genetic testing is imperative to advance precision medicine for diabetes. The objective of this article is to assess the cost-effectiveness of genetic testing, preceded by biomarker screening and followed by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Genomics and Rare Diseases
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31558549
DOI: 10.2337/dc19-0486

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic TestingPMID 31558549Read ↗

Search for a time- and cost-saving genetic testing strategy for maturity-onset diabetes of the young.Semantic proximity Read ↗

Monogenic diabetes: Implementation of translational genomic research towards precision medicineSemantic proximity Read ↗

A decade of molecular genetic testing for MODY: a retrospective study of utilization in The Netherlands.Semantic proximity Read ↗

A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathySemantic proximity Read ↗

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness modelSemantic proximity Read ↗

Cascade health service use in family members following genetic testing in children: a scoping literature reviewSemantic proximity Read ↗

Economic Evaluation of a New Polygenic Risk Score to Predict Nephropathy in Adult Patients With Type 2 Diabetes.Semantic proximity Read ↗

Comparison of Decision Modeling Approaches for Health Technology and Policy EvaluationSemantic proximity Read ↗

Early economic modelling of a new pharmacotherapeutic treatment pathway for children with monogenic obesitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.